Purdue Pharma is offering up to $12 billion to settle lawsuits over its role in the opioid epidemic; the US Preventive Services Task Force is aiming to expand its hepatitis C virus (HCV) screening recommendations to include all adults aged 18 to 79 years; the majority of Democratic voters would be more likely to support a candidate that backs a single-payer health system like Medicare for All.
In an effort to settle over 2000 lawsuits against the company for its role in the opioid epidemic, Purdue Pharma is offering $10 billion to $12 billion. The lawsuits, brought by states, cities, and counties, allege that Purdue Pharma and the Sackler family are responsible for fueling and maintaining the opioid crisis. According to NBC News, the offer was part of confidential conversations and discussed by the opioid maker’s lawyers at a meeting last week. At least 10 state attorneys general and Purdue Pharma’s attorneys met in Cleveland where David Sackler represented the family.
Amid a rise of hepatitis C virus in younger people, the US Preventive Services Task Force is aiming to expand its recommendations for screening for the viral infection. According to The Wall Street Journal, the panel is aiming to recommend that all adults aged 18 to 79 years get screened for hepatitis C, which would expand on the 2013 recommendation to screen those born between 1945 and 1965. CDC data has shown that the baby boomer generation accounts for approximately 75% of those living with the infection. However, in the last decade, acute incidence among younger people has expanded rapidly, which experts attribute to the opioid epidemic.
A Politico/Morning Consult poll has found that 65% of Democratic primary voters would be more willing to support a candidate who is in favor of a single-payer healthcare system, such as Medicare for All. Meanwhile, 13% said they would be less likely to support a candidate based on their support of it. The survey included 1987 registered voters, including 768 Democratic voters. Nearly half (45%) of voters said that a candidate’s support of Medicare for All would make them more likely to vote for them over a candidate that supports building on the Affordable Care Act.
Alopecia Areata Impacts Patient Perception, Quality of Life
March 27th 2024Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen